In addition, MC3324, a dual inhibitor of LSD1 and KDM6A/B, increased H3K4me2 and H3K27me3, followed by growth arrest and enhanced apoptosis of prostate cancer cells, downregulation of AR, and impairment of cellular metabolism. This evidence concerns the gene KDM1A and prostate carcinoma.